Study design
Ovarian Cancer
OVARIAN CANCER, BREAST
The study was designed as a monocentric RCT and conducted at the Center for Familial Breast and Ovarian Cancer at the University Hospital Cologne, Germany [registered as DRKS00015823]. Enrollment started in January 2019 and ended in October 2021. Data were collected at baseline (t0), three months (t1), and six months (t2) after study inclusion. The study protocol has been published elsewhere [